Daiju Kitagawa
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Daiju Kitagawa has a total of 111 co-authors. Here are the top co-authors by number of shared publications:
Takumi Chinen
Graduate School of Pharmaceutical Science, The University of Tokyo
18 shared publicationsMasamitsu Fukuyama
Department of Physiological Chemistry, Graduate School of Pharmaceutical Sciences, The University of Tokyo, Bunkyo, Tokyo, Japan
16 shared publicationsShohei Yamamoto
Department of Physiological Chemistry, Graduate School of Pharmaceutical Sciences, The University of Tokyo, Bunkyo, Tokyo, Japan
14 shared publications- Shoji Hata
Department of Physiological Chemistry, Graduate School of Pharmaceutical Sciences, The University of Tokyo, Bunkyo, Tokyo, Japan
13 shared publications Koki Watanabe
Department of Physiological Chemistry, Graduate School of Pharmaceutical Science, The University of Tokyo, Bunkyo, Japan
11 shared publications- Takumi Chinen
The University of Tokyo
10 shared publications
Latest Publications
- Open Access
- 16 September 2026
- Published by Springer Nature in Research Square
PCYT1A is a lineage-specific metabolic vulnerability in monocytic acute myeloid leukemia
Monocytic acute myeloid leukemia (AML) exhibits intrinsic resistance to standard therapies like venetoclax, highlighting an urgent need for novel strategies. Using a custom computational pipeline analyzing DepMap datasets, we identified PCYT1A , the rate-limiting enzyme for the de novo phosphatidylcholine (PC) synthesis via the Kennedy pathway, as a critical lineage-specific dependency in monocytic AML. This vulnerability represents a unique synthetic lethality driven by the transcriptional suppression of its paralog, PCYT1B , in the monocytic lineage. We demonstrate that PCYT1A deficiency triggers compensatory PEMT upregulation and remodeling of methionine-cycle-associated metabolite pools, followed by a progressive loss of relative phosphatidylcholine abundance and disruption of lipid homeostasis associated with terminal differentiation, apoptosis, and mitotic defects. PCYT1A depletion also suppresses leukemic progression in vivo in xenograft models. Furthermore, we show that monocytic AML is characterized by elevated choline transporter expression, reflecting a physiological "choline addiction" hijacked by leukemic cells. Pharmacological inhibition of the PC de novo synthesis pathway robustly synergizes with venetoclax and conventional therapies. Our findings uncover a metabolic Achilles' heel rooted in the inherent lipid homeostasis of the monocytic cell of origin, providing a strong rationale for targeting the PC de novo synthesis pathway to overcome treatment resistance in aggressive AML.
- 16 September 2026
- Published by Springer Nature in Research Square
Open AccessPCYT1A is a lineage-specific metabolic vulnerability in monocytic acute myeloid leukemia
Monocytic acute myeloid leukemia (AML) exhibits intrinsic resistance to standard therapies like venetoclax, highlighting an urgent need for novel strategies. Using a custom computational pipeline analyzing DepMap datasets, we identified PCYT1A , the rate-limiting enzyme for the de novo phosphatidylcholine (PC) synthesis via the Kennedy pathway, as a critical lineage-specific dependency in monocytic AML. This vulnerability represents a unique synthetic lethality driven by the transcriptional suppression of its paralog, PCYT1B , in the monocytic lineage. We demonstrate that PCYT1A deficiency triggers compensatory PEMT upregulation and remodeling of methionine-cycle-associated metabolite pools, followed by a progressive loss of relative phosphatidylcholine abundance and disruption of lipid homeostasis associated with terminal differentiation, apoptosis, and mitotic defects. PCYT1A depletion also suppresses leukemic progression in vivo in xenograft models. Furthermore, we show that monocytic AML is characterized by elevated choline transporter expression, reflecting a physiological "choline addiction" hijacked by leukemic cells. Pharmacological inhibition of the PC de novo synthesis pathway robustly synergizes with venetoclax and conventional therapies. Our findings uncover a metabolic Achilles' heel rooted in the inherent lipid homeostasis of the monocytic cell of origin, providing a strong rationale for targeting the PC de novo synthesis pathway to overcome treatment resistance in aggressive AML.
- Open Access
AKIP1 is an inner scaffold component required for centriole integrity
Centrioles are microtubule-based organelles that play crucial roles in various biological processes, including cell division, ciliogenesis and flagellar assembly. These functions require the preservation of centriole structural integrity, yet the molecular mechanisms that maintain this integrity remain incompletely understood. In this study, through large-scale gene co-dependency analysis and ultrastructure expansion microscopy (U-ExM), we identified A-kinase interacting protein 1 (AKIP1) as a novel component of the centriole inner scaffold, a luminal structural framework that supports centriole integrity. Analysis of large-scale functional genomic data from DepMap placed AKIP1 in a functional cluster with the inner scaffold components POC1A, POC1B, and POC5. Consistently, AKIP1 colocalizes with these clustered inner scaffold components in the central core region of centrioles, forming a multicomponent interaction network. We further show that AKIP1 is recruited to centrioles during G2 phase, subsequent to the recruitment of other inner scaffold components, and that its centriolar localization depends on these components. AKIP1 depletion leads to defects in centriolar microtubules and abnormal centriole morphology. Together, our findings establish AKIP1 as a downstream component of the inner scaffold that contributes to the maintenance of centriole integrity.
Open AccessAKIP1 is an inner scaffold component required for centriole integrity
Centrioles are microtubule-based organelles that play crucial roles in various biological processes, including cell division, ciliogenesis and flagellar assembly. These functions require the preservation of centriole structural integrity, yet the molecular mechanisms that maintain this integrity remain incompletely understood. In this study, through large-scale gene co-dependency analysis and ultrastructure expansion microscopy (U-ExM), we identified A-kinase interacting protein 1 (AKIP1) as a novel component of the centriole inner scaffold, a luminal structural framework that supports centriole integrity. Analysis of large-scale functional genomic data from DepMap placed AKIP1 in a functional cluster with the inner scaffold components POC1A, POC1B, and POC5. Consistently, AKIP1 colocalizes with these clustered inner scaffold components in the central core region of centrioles, forming a multicomponent interaction network. We further show that AKIP1 is recruited to centrioles during G2 phase, subsequent to the recruitment of other inner scaffold components, and that its centriolar localization depends on these components. AKIP1 depletion leads to defects in centriolar microtubules and abnormal centriole morphology. Together, our findings establish AKIP1 as a downstream component of the inner scaffold that contributes to the maintenance of centriole integrity.
- Open Access
Pathway-Centric Integration of CRISPR Fitness with Molecular Features Draws Cancer State Maps
Cancer cells display heterogeneous pathway activity that shapes therapeutic vulnerability, but mapping it remains challenging. Transcriptomic scores do not directly measure functional activity, and CRISPR knockout data alone lack molecular interpretability. We introduce StateMap, a pathway-centric framework integrating gene expression and genome-wide CRISPR knockout fitness data from the Cancer Dependency Map. For a given pathway, StateMap selects features by co-dependency and mutual information, then projects cell lines into a low-dimensional space reflecting pathway activity and molecular state. Applied to the Hippo pathway, it resolved five functional states refining the YAP-on/YAP-off dichotomy. Notably, the 'Hippo-strong' state showed selective dependence on integrin αVβ5; ITGAV depletion triggered Hippo-dependent cell aggregation and G1 arrest via enhanced cell-cell adhesion. Machine learning transfer to TCGA identified a matching subtype with poor prognosis, nominated NNMT as a biomarker, and predicted sensitivity to the αV inhibitor Cilengitide. StateMap enables pathway-specific state mapping and discovery of state-selective therapeutic vulnerabilities.
Open AccessPathway-Centric Integration of CRISPR Fitness with Molecular Features Draws Cancer State Maps
Cancer cells display heterogeneous pathway activity that shapes therapeutic vulnerability, but mapping it remains challenging. Transcriptomic scores do not directly measure functional activity, and CRISPR knockout data alone lack molecular interpretability. We introduce StateMap, a pathway-centric framework integrating gene expression and genome-wide CRISPR knockout fitness data from the Cancer Dependency Map. For a given pathway, StateMap selects features by co-dependency and mutual information, then projects cell lines into a low-dimensional space reflecting pathway activity and molecular state. Applied to the Hippo pathway, it resolved five functional states refining the YAP-on/YAP-off dichotomy. Notably, the 'Hippo-strong' state showed selective dependence on integrin αVβ5; ITGAV depletion triggered Hippo-dependent cell aggregation and G1 arrest via enhanced cell-cell adhesion. Machine learning transfer to TCGA identified a matching subtype with poor prognosis, nominated NNMT as a biomarker, and predicted sensitivity to the αV inhibitor Cilengitide. StateMap enables pathway-specific state mapping and discovery of state-selective therapeutic vulnerabilities.
- Open Access
- 8 September 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-18
The DNA replication machinery transmits dual signals to prevent unscheduled licensing and execution of centrosome duplication
Copy number control of DNA and centrosomes is essential for accurate genetic inheritance. DNA replication and centrosome duplication have been recognized as parallel key events for cell division. Here, we discover that the DNA replication machinery directly regulates the licensing and execution processes of centrosome duplication to prevent centrosome amplification. We find that the microcephaly protein DONSON couples DNA replication initiation with Cdc6 translocation to centrosomes. The Cdc6 signal prevents the precocious occurrence of centriole disengagement, the licensing step for centrosome duplication. During DNA replication, DONSON inhibits replisome disassembly by interacting with the CMG helicase, maintaining the intrinsic S/G2 checkpoint signal that blocks centriole-to-centrosome conversion, the execution step for centrosome duplication. Disruption of these dual signals causes precocious centrosome duplication and chromosome mis-segregation, observed in DONSON patient cells. Our results reveal that the DNA replication machinery not only duplicates genetic material but also controls the system for its accurate segregation.
- 8 September 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-18
Open AccessThe DNA replication machinery transmits dual signals to prevent unscheduled licensing and execution of centrosome duplication
Copy number control of DNA and centrosomes is essential for accurate genetic inheritance. DNA replication and centrosome duplication have been recognized as parallel key events for cell division. Here, we discover that the DNA replication machinery directly regulates the licensing and execution processes of centrosome duplication to prevent centrosome amplification. We find that the microcephaly protein DONSON couples DNA replication initiation with Cdc6 translocation to centrosomes. The Cdc6 signal prevents the precocious occurrence of centriole disengagement, the licensing step for centrosome duplication. During DNA replication, DONSON inhibits replisome disassembly by interacting with the CMG helicase, maintaining the intrinsic S/G2 checkpoint signal that blocks centriole-to-centrosome conversion, the execution step for centrosome duplication. Disruption of these dual signals causes precocious centrosome duplication and chromosome mis-segregation, observed in DONSON patient cells. Our results reveal that the DNA replication machinery not only duplicates genetic material but also controls the system for its accurate segregation.
- Open Access
- 13 May 2025
- Published by Springer Nature in Communications Biology
- Vol. 8 (1) , 1-12
Comparative analysis of multiple DNA double-strand break repair pathways in CRISPR-mediated endogenous tagging
CRISPR-mediated endogenous tagging is a powerful tool in biological research. Inhibiting the non-homologous end joining (NHEJ) pathway has been shown to improve the low efficiency of accurate knock-in via homology-directed repair (HDR). However, the influence of alternative double-stranded break (DSB) repair pathways on knock-in remains to be fully explored. In this study, our long-read amplicon sequencing analysis reveals various patterns of imprecise repair in CRISPR-mediated knock-in, even with NHEJ inhibition. Further suppressing either microhomology-mediated end joining (MMEJ) or single-strand annealing (SSA) reduces nucleotide deletions around the cut site, thereby elevating knock-in accuracy. Additionally, imprecise donor integration is reduced by inhibiting SSA, but not MMEJ. Particularly, SSA suppression reduced asymmetric HDR, a specific imprecise integration pattern, which we further confirm using a novel reporter system. These findings demonstrate the complex interplay of multiple DSB repair pathways in CRISPR-mediated knock-in and offer novel strategies, including SSA pathway targeting, to improve precise gene editing efficiency.
- 13 May 2025
- Published by Springer Nature in Communications Biology
- Vol. 8 (1) , 1-12
Open AccessComparative analysis of multiple DNA double-strand break repair pathways in CRISPR-mediated endogenous tagging
CRISPR-mediated endogenous tagging is a powerful tool in biological research. Inhibiting the non-homologous end joining (NHEJ) pathway has been shown to improve the low efficiency of accurate knock-in via homology-directed repair (HDR). However, the influence of alternative double-stranded break (DSB) repair pathways on knock-in remains to be fully explored. In this study, our long-read amplicon sequencing analysis reveals various patterns of imprecise repair in CRISPR-mediated knock-in, even with NHEJ inhibition. Further suppressing either microhomology-mediated end joining (MMEJ) or single-strand annealing (SSA) reduces nucleotide deletions around the cut site, thereby elevating knock-in accuracy. Additionally, imprecise donor integration is reduced by inhibiting SSA, but not MMEJ. Particularly, SSA suppression reduced asymmetric HDR, a specific imprecise integration pattern, which we further confirm using a novel reporter system. These findings demonstrate the complex interplay of multiple DSB repair pathways in CRISPR-mediated knock-in and offer novel strategies, including SSA pathway targeting, to improve precise gene editing efficiency.
- Open Access
- 4 February 2025
- Published by Springer Nature in The EMBO Journal
- Vol. 44 (5) , 1294-1321
Multimodal mechanisms of human centriole engagement and disengagement
Centrioles are unique cellular structures that replicate to produce identical copies, ensuring accurate chromosome segregation during mitosis. A new centriole, the “daughter”, is assembled adjacent to an existing “mother” centriole. Only after the daughter centriole is fully developed as a complete replica, does it disengage and become the core of a new functional centrosome. The mechanisms preventing precocious disengagement of the immature daughter centriole have remained unclear. Here, we identify three key mechanisms maintaining mother–daughter centriole engagement: the cartwheel, the torus, and the pericentriolar material (PCM). Among these, the torus critically establishes the characteristic orthogonal engagement. We also demonstrate that engagement mediated by the cartwheel and torus is progressively released during centriole maturation. This release involves structural changes in the daughter, known as centriole blooming and distancing, respectively. Disrupting these structural transitions blocks subsequent steps, preventing centriole disengagement and centrosome conversion in the G1 phase. This study provides a comprehensive understanding of how the maturing daughter centriole progressively disengages from its mother through multiple steps, ensuring its complete structure and conversion into an independent centrosome.
- 4 February 2025
- Published by Springer Nature in The EMBO Journal
- Vol. 44 (5) , 1294-1321
Open AccessMultimodal mechanisms of human centriole engagement and disengagement
Centrioles are unique cellular structures that replicate to produce identical copies, ensuring accurate chromosome segregation during mitosis. A new centriole, the “daughter”, is assembled adjacent to an existing “mother” centriole. Only after the daughter centriole is fully developed as a complete replica, does it disengage and become the core of a new functional centrosome. The mechanisms preventing precocious disengagement of the immature daughter centriole have remained unclear. Here, we identify three key mechanisms maintaining mother–daughter centriole engagement: the cartwheel, the torus, and the pericentriolar material (PCM). Among these, the torus critically establishes the characteristic orthogonal engagement. We also demonstrate that engagement mediated by the cartwheel and torus is progressively released during centriole maturation. This release involves structural changes in the daughter, known as centriole blooming and distancing, respectively. Disrupting these structural transitions blocks subsequent steps, preventing centriole disengagement and centrosome conversion in the G1 phase. This study provides a comprehensive understanding of how the maturing daughter centriole progressively disengages from its mother through multiple steps, ensuring its complete structure and conversion into an independent centrosome.
- Open Access
Latent mitotic vulnerability of AML cells induced by therapeutic agents
Acute myeloid leukemia (AML) is a hematopoietic malignancy with a poor prognosis. Understanding the unidentified properties of AML cells is beneficial for the identification of novel therapeutic strategies for AML. In this study, we uncover the vulnerabilities of AML cells in mitosis when exposed to therapeutic agents. Through comparative analysis of large-scale data quantifying drug effects on cancer cell proliferation, the drug targeting the cell cycle and mitosis are predicted to possess high cytotoxicity against AML cell lines. Consistently, live-cell imaging with microwell devices demonstrates that clinical drugs targeting the cell cycle processes, such as idarubicin, pevonedistat and vincristine, potently induce mitotic cell death in AML cells. While these therapeutic agents also induce cell death through S/G2 phase arrest, the cytotoxic effects during mitosis are notably more pronounced. Furthermore, by employing additional inhibition of Chk1 to override the G2/M checkpoint, the AML cells stalled in the S/G2 phase prematurely enter mitosis, resulting in a significant increase in cell death. Collectively, these results unveiled the latent mitotic vulnerabilities of AML cells, providing a basis for developing novel therapeutic interventions.
Open AccessLatent mitotic vulnerability of AML cells induced by therapeutic agents
Acute myeloid leukemia (AML) is a hematopoietic malignancy with a poor prognosis. Understanding the unidentified properties of AML cells is beneficial for the identification of novel therapeutic strategies for AML. In this study, we uncover the vulnerabilities of AML cells in mitosis when exposed to therapeutic agents. Through comparative analysis of large-scale data quantifying drug effects on cancer cell proliferation, the drug targeting the cell cycle and mitosis are predicted to possess high cytotoxicity against AML cell lines. Consistently, live-cell imaging with microwell devices demonstrates that clinical drugs targeting the cell cycle processes, such as idarubicin, pevonedistat and vincristine, potently induce mitotic cell death in AML cells. While these therapeutic agents also induce cell death through S/G2 phase arrest, the cytotoxic effects during mitosis are notably more pronounced. Furthermore, by employing additional inhibition of Chk1 to override the G2/M checkpoint, the AML cells stalled in the S/G2 phase prematurely enter mitosis, resulting in a significant increase in cell death. Collectively, these results unveiled the latent mitotic vulnerabilities of AML cells, providing a basis for developing novel therapeutic interventions.
- Open Access
Comprehensive analysis of end-modified long dsDNA donors in CRISPR-mediated endogenous tagging
CRISPR-mediated endogenous tagging is a powerful gene editing technique for studying protein dynamics and function in their native cellular environment. While the use of 5’ modified DNA donors has emerged as a promising strategy to improve the typically low efficiency of knock-in gene editing, the underlying mechanisms remain poorly understood. In this study, we conducted a comprehensive analysis of end-modified long linear dsDNA donors in CRISPR-mediated endogenous tagging in human non-transformed cells. In-depth analysis of repair patterns reveals that 5’ biotinylation of dsDNA donors significantly reduces imprecise insertions, thereby enhancing homology-directed repair (HDR)-mediated precise insertion efficiency. Notably, the impact of biotinylation on repair patterns resembles that of non-homologous end joining (NHEJ) pathway inhibition, suggesting its role in preventing NHEJ-mediated mis-integration. Moreover, combining biotin modification with NHEJ inhibitor treatment further improves bi-allelic knock-in efficiency. Overall, this study provides novel insights into the mechanisms by which 5’ modifications enhance precise knock-ins and demonstrates their potential for achieving high-efficient, prercise endogenous tagging in human cells.
Open AccessComprehensive analysis of end-modified long dsDNA donors in CRISPR-mediated endogenous tagging
CRISPR-mediated endogenous tagging is a powerful gene editing technique for studying protein dynamics and function in their native cellular environment. While the use of 5’ modified DNA donors has emerged as a promising strategy to improve the typically low efficiency of knock-in gene editing, the underlying mechanisms remain poorly understood. In this study, we conducted a comprehensive analysis of end-modified long linear dsDNA donors in CRISPR-mediated endogenous tagging in human non-transformed cells. In-depth analysis of repair patterns reveals that 5’ biotinylation of dsDNA donors significantly reduces imprecise insertions, thereby enhancing homology-directed repair (HDR)-mediated precise insertion efficiency. Notably, the impact of biotinylation on repair patterns resembles that of non-homologous end joining (NHEJ) pathway inhibition, suggesting its role in preventing NHEJ-mediated mis-integration. Moreover, combining biotin modification with NHEJ inhibitor treatment further improves bi-allelic knock-in efficiency. Overall, this study provides novel insights into the mechanisms by which 5’ modifications enhance precise knock-ins and demonstrates their potential for achieving high-efficient, prercise endogenous tagging in human cells.
- Open Access
Multimodal mechanisms of human centriole engagement and disengagement
The DNA and the centrioles are the only cellular structures that uniquely replicate to produce identical copies, which is crucial for proper chromosome segregation in mitosis. A new centriole termed “daughter” is progressively assembled adjacent to a pre-existing, “mother” centriole. Only after the daughter centriole is structurally completed as an identical copy, it disengages from its mother to become the core of a new functional centrosome. The mechanisms preventing precocious disengagement of the immature copy have been previously unknown. Here, we identify three key centriole-associated mechanisms that maintain the mother-daughter engagement: the cartwheel, the torus, and the pericentriolar material pathways. Among these, the torus is critical for establishing the characteristic orthogonal engagement between the mother and daughter centrioles. Furthermore, we show that the engagement mediated by the cartwheel and the torus pathways is released stepwise through structural changes in the daughter centriole, known as centriole blooming and centriole distancing, respectively. Disruption at any stage of these structural transitions leads to the failure of all subsequent steps, ultimately blocking centriole disengagement and centrosome conversion at the end of mitosis. Overall, this study provides a comprehensive understanding of how the maturing daughter centriole progressively disengages from its mother through multiple maturation steps, to ensure its complete structure and conversion into an independent centrosome.
Open AccessMultimodal mechanisms of human centriole engagement and disengagement
The DNA and the centrioles are the only cellular structures that uniquely replicate to produce identical copies, which is crucial for proper chromosome segregation in mitosis. A new centriole termed “daughter” is progressively assembled adjacent to a pre-existing, “mother” centriole. Only after the daughter centriole is structurally completed as an identical copy, it disengages from its mother to become the core of a new functional centrosome. The mechanisms preventing precocious disengagement of the immature copy have been previously unknown. Here, we identify three key centriole-associated mechanisms that maintain the mother-daughter engagement: the cartwheel, the torus, and the pericentriolar material pathways. Among these, the torus is critical for establishing the characteristic orthogonal engagement between the mother and daughter centrioles. Furthermore, we show that the engagement mediated by the cartwheel and the torus pathways is released stepwise through structural changes in the daughter centriole, known as centriole blooming and centriole distancing, respectively. Disruption at any stage of these structural transitions leads to the failure of all subsequent steps, ultimately blocking centriole disengagement and centrosome conversion at the end of mitosis. Overall, this study provides a comprehensive understanding of how the maturing daughter centriole progressively disengages from its mother through multiple maturation steps, to ensure its complete structure and conversion into an independent centrosome.
- Open Access
- 22 March 2024
- Published by Springer Nature in Nature Communications
- Vol. 15 (1) , 1-15
Molecular basis promoting centriole triplet microtubule assembly
The triplet microtubule, a core structure of centrioles crucial for the organization of centrosomes, cilia, and flagella, consists of unclosed incomplete microtubules. The mechanisms of its assembly represent a fundamental open question in biology. Here, we discover that the ciliopathy protein HYLS1 and the β-tubulin isotype TUBB promote centriole triplet microtubule assembly. HYLS1 or a C-terminal tail truncated version of TUBB generates tubulin-based superstructures composed of centriole-like incomplete microtubule chains when overexpressed in human cells. AlphaFold-based structural models and mutagenesis analyses further suggest that the ciliopathy-related residue D211 of HYLS1 physically traps the wobbling C-terminal tail of TUBB, thereby suppressing its inhibitory role in the initiation of the incomplete microtubule assembly. Overall, our findings provide molecular insights into the biogenesis of atypical microtubule architectures conserved for over a billion years.
- 22 March 2024
- Published by Springer Nature in Nature Communications
- Vol. 15 (1) , 1-15
Open AccessMolecular basis promoting centriole triplet microtubule assembly
The triplet microtubule, a core structure of centrioles crucial for the organization of centrosomes, cilia, and flagella, consists of unclosed incomplete microtubules. The mechanisms of its assembly represent a fundamental open question in biology. Here, we discover that the ciliopathy protein HYLS1 and the β-tubulin isotype TUBB promote centriole triplet microtubule assembly. HYLS1 or a C-terminal tail truncated version of TUBB generates tubulin-based superstructures composed of centriole-like incomplete microtubule chains when overexpressed in human cells. AlphaFold-based structural models and mutagenesis analyses further suggest that the ciliopathy-related residue D211 of HYLS1 physically traps the wobbling C-terminal tail of TUBB, thereby suppressing its inhibitory role in the initiation of the incomplete microtubule assembly. Overall, our findings provide molecular insights into the biogenesis of atypical microtubule architectures conserved for over a billion years.